Connect with us

Medical Science

14 Things You Need to Know About COVID-19

(Asian News Hub) – We’ve collected the most important updates about COVID-19 this week.

Just 2% of People Are Responsible for 90% of SARS-CoV-2 Transmissions.


A few “super carriers” with off-the-charts viral loads are likely responsible for the bulk of SARS-CoV-2 transmissions, while about half of infected people aren’t contagious at all.

Keep Using AstraZeneca COVID-19 Vaccine, WHO Urges World.


“We urge countries to continue using this important COVID-19 vaccine,” WHO Director General Tedros Adhanom Ghebreyesus told the world at a news conference in Geneva.

SARS-CoV-2 Circulated Undetected Months Before First COVID-19 Cases in Wuhan | SOURCE
Researchers estimate that the SARS-CoV-2 virus likely circulated undetected for two months before the first human cases of COVID-19 were described in Wuhan, China in December 2019.

Leaked Documents Reveal Early Batches of Pfizer COVID-19 Vaccine Less Potent Than We Were Told


A cyberattack on the European Medicines Agency as it was reviewing the Pfizer COVID-19 vaccine captured a trove of data, subsequently released on the dark web and sent to several journalists and academics by as-yet-unidentified entities.

CDC Now Says 3 Feet of Social Distance is Enough for Kids as Long as They Have Masks On.


The CDC shifted its physical distancing guidance for K-12 schools across the country, saying three feet of distance is generally enough between students—as long as they’re masked up.

Norwegian Experts Say Deadly Blood Clots Were Caused by the AstraZeneca COVID-19 Vaccine.


“The reason for the condition of our patients has been found,” chief physician and professor Pål Andre Holme announced to Norwegian national newspaper VG. “Our theory that this is a powerful immune response most likely triggered by the vaccine, has been confirmed.”

Biden to Send 4,000,000 AstraZeneca COVID-19 Vaccine Doses to Mexico, Canada.


The Biden administration is sending Mexico (2.5 million doses) and Canada (1.5 million doses) 4 million doses of the AstraZeneca COVID-19 vaccine, which has not yet been approved in the US.

Moderna Begins Testing COVID-19 Vaccine on Young Children, Infants.


Moderna has begun testing its COVID-19 vaccine on children and infants between the ages of six months and 12 years old in a study, as the pharmaceutical company seeks to expand approval for its vaccine to children.

Brazil Struggles With Lack of ICU Doctors as COVID-19 Pandemic Worsens.


As Brazil’s COVID-19 outbreak worsens, the country is facing a shortage of ICU doctors, threatening to drive deaths higher.

Dr. John Campbell Reviews Ivermectin Evidence with Dr. Tess Lawrie.


What’s the truth about Ivermectin? Why is there so much controversy? Two top doctors dive into the evidence.

Women More Likely to Experience Serious Side Effects From COVID-19 Vaccine: CDC Study


A new CDC study found women were more likely to have serious side effects from the COVID-19 vaccine.

COVID-19 Spiking in Over a Dozen States—Most With High Vaccination Rates.


New SARS-CoV-2 cases are again spiking in 13 U.S. states, including some states among the highest in vaccination rates.

Censorship Kills: The Shunning of a COVID Therapeutic


Doctors fighting COVID-19 should be supported by their profession and their government, not suppressed. Yet today physicians are smothered under a wave of censorship.

Injection of Female Hormone May Improve COVID-19 Outcomes for Men: Study Finds


The pilot clinical trial, involving 40 men, is the first published study to use progesterone to treat male COVID-19 patients.

Continue Reading

Medical Science

AstraZeneca could have COVID-19 vaccine against variant by end of 2021

(Asian News Hub) – A modified version of AstraZeneca’s (AZN.L) COVID-19 vaccine tailored to combat a coronavirus variant first documented in South Africa could be ready by the end of 2021, an AstraZeneca official in Austria said in an interview published on Sunday.

Sarah Walters, AstraZeneca’s Austria country manager, told the Kurier newspaper that studies, so far, indicating the existing AstraZeneca vaccine was less effective against the more infectious variant first documented in South Africa were “too small to draw final conclusions”.

“In the meantime, AstraZeneca and Oxford University have started on modifications to the vaccine for the South African variant and we expect it will be ready by the end of the year, should it be needed,” Walters told the Kurier.

Walters blamed challenges – including delivery delays for the AstraZeneca shot in the European Union – on the “complex process” of producing a vaccine, coupled with the extremely high demand arising from the coronavirus pandemic.

“We had to work without keeping a supply in reserve. As a result, we couldn’t make up for unexpected events,” she said. “We are confident that we will fulfill our commitment to deliver 300 million doses to the European Union this year.”

The Kurier interview did not directly address ongoing investigations into health concerns over the AstraZeneca shot. The EU has put a warning label on the vaccine over its possible linkage to extremely rare blood clots, Denmark has completely halted use of the vaccine and Britain has advised people under 30 to get another brand of vaccine.

Asked about “thousands” of people in Austria who are cancelling their appointments for AstraZeneca shots, Walters said the company’s plan was “to continue to transparently provide information about efficacy and safety to doctors, so that they can adequately inform people” of benefits and risks.

British and European Union medicine regulators have said that the overall benefits of using the vaccine outweigh any risks of rare clotting.

Reuters

Continue Reading

Medical Science

N95 masks are a must as COVID-19 spreads via airborne transmission too: AIIMS Chief

(Asian News Hub) – AIIMS chief Randeep Guleria said on Sunday that the fact that coronavirus can be transmitted through aerosols makes it more contagious since these are much smaller and lighter particles than droplets.

Because of their small size, aerosols can hang in the air and travel a distance of even up to 10 metres. He emphasised the need to use N95 masks for staying safe from the deadly disease.

Until now the emphasis has been that coronavirus is transmitted predominantly through droplets while coughing or sneezing. However, a study published in the reputed British medical journal The Lancet this week concludes that coronavirus spreads predominantly through airborne transmission.

Since the disease is airborne a social distance of 3 metres is not enough to keep you safe and you can get infected even after a person has left the immediate vicinity as the virus could be lingering in the air.

Speaking on NDTV, Dr Guleria said the debate of droplets versus aerosols has been going on for the last eight or nine months but the fact that the disease can be transmitted through aerosols which can travel through longer distances in the air makes the disease more contagious.

He said the virus from an infected person can linger in the air for much longer when it is carried in aerosols as these are much smaller particles than droplets which drop to the ground in the immediate vicinity.
Thus while a social distance of 3 metres is enough in the case of droplets, when it comes to aerosols the distance which the virus can travel could go up to 10 metres.

He said it is essential, therefore, to keep all rooms well ventilated so that aerosols are not left hanging in the air. The doors and windows of a room should be kept open, he added.

Guleria also said that meetings should not be held in closed rooms as if there is an infected person he can leave aerosols in the air. These are left floating in the air even after the person has left.

The AIIMS chief said it was also important to wear N95 masks as these can effectively stop the virus. But he emphasised that the mask should be worn properly so that it completely seals the nose and mouth. One must ensure that no air enters from the sides of the mask. N95 masks are a must.

He also said that in the case of a surgical mask or cloth masks, which are not as effective as N95 masks, wearing two masks helps as this provides a double layer of protection.

But if it is an N95 mask worn properly, then one mask is enough, he added.

AGENCY

Continue Reading

Medical Science

Covid-19 is primarily airborne: Lancet

(Asian News Hub) – A report in The Lancet journal has dismissed the predominant scientific view that SARS-CoV-2, the coronavirus that causes Covid-19, is not an airborne pathogen.

Areport published in the journal The Lancet has dismissed the predominant scientific view that SARS-CoV-2, the coronavirus that causes Covid-19, is not an airborne pathogen. The authors of the report have listed 10 reasons for their claim that “SARS-CoV-2 is transmitted primarily by the airborne route”.

The paper, written by six experts from the UK, the US and Canada, argues that there are “insufficient grounds for concluding that a pathogen is not airborne” while “the totality of scientific evidence indicates otherwise”. The experts called for urgent modification in the Covid-19 safety protocol.

CORONAVIRUS IS AIRBORNE: 10 REASONS CITED BY THE RESEARCHERS

  1. “Superspreading events account for substantial SARS-CoV-2 transmission; indeed, such events may be the pandemic’s primary drivers,” they said. Detailed analyses of human behaviours and interactions, room sizes, ventilation, and other variables, the authors said, are consistent with airborne spread of SARS-CoV-2 and the same cannot be adequately explained by droplets or fomites.
  2. Long-range transmission of SARS-CoV-2 between people in adjacent rooms but never in each other’s presence has been documented in quarantine hotels, the paper said.
  3. The experts argued that from 33 per cent to 59 per cent of all Covid-19 cases could be attributed to asymptomatic or presymptomatic transmission of SARS-CoV-2 from people who are not coughing or sneezing. They said this supported a predominantly airborne mode of transmission.
  4. Transmission of SARS-CoV-2 is higher indoors than outdoors and is substantially reduced by indoor ventilation.
  5. The paper said nosocomial infections (those that originate in a hospital) had been documented even at places where healthcare professionals used personal protective equipment (PPE) designed to protect against droplet but not aerosol exposure.
  6. The experts said viable SARS-CoV-2 has been detected in the air. In laboratory experiments, SARS-CoV-2 stayed infectious in the air for up to 3 hours. They rejected the argument that SARS-CoV-2 was bit cultivated from air arguing that measles and tuberculosis, two primarily airborne diseases, had never been cultivated from room air.
  7. SARS-CoV-2 has been identified in air filters and building ducts in hospitals with COVID-19 patients; such locations could be reached only by aerosols, they said.
  8. The experts cited studies involving infected caged animals that showed transmission of SARS-CoV-2 via an air duct.
  9. Another argument of the experts was that no study to our knowledge provided strong or consistent evidence to refute the hypothesis of airborne SARS-CoV-2 transmission.
  10. Their final argument was that there was limited evidence to support other dominant routes of transmission- i.e. respiratory droplet or fomite.

The claim of the experts, if proven and accepted, could have massive implications on counter-Covid-19 strategy across the world. This may require the people to wear mask even inside their homes, and possibly at all times.

The current understanding is that SARS-CoV-2 spreads through smaller aerosols that stay suspended in air or through fomites, the surfaces where the virus gets deposited, and could be picked by a health person. Gravity pulls down heavier droplets reducing the chances of infection considerably.

But if an infectious virus is mainly airborne, an individual could potentially be infected when they inhale aerosols produced when an infected person exhales, speaks, shouts, sings, sneezes, or coughs, the experts said. This changes the way the world should fight coronavirus pandemic.

Continue Reading

Trending